10X Fund, L.P. Reports Disposal of Galectin Therapeutics Inc. Common Shares
10X Fund, L.P. has reported the disposal of common shares of Galectin Therapeutics Inc. The filing was made by multiple reporting persons, including 10X Fund, L.P. The original content was published by Galectin Therapeutics Inc. via the SEC's EDGAR system.
10X Fund, L.P., a beneficial owner, has reported a disposal of common shares of Galectin Therapeutics Inc. (GALT). The Form 4 was filed by more than one reporting person, including 10X Fund, L.P. and other reporting beneficial owners. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-026204), on December 04, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
